These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11207826)

  • 41. Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
    Vrotsos E; Alexis J
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):26-9. PubMed ID: 25611246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma.
    Weissinger SE; Keil P; Silvers DN; Klaus BM; Möller P; Horst BA; Lennerz JK
    Mod Pathol; 2014 Apr; 27(4):524-34. PubMed ID: 24051699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small cell malignant melanoma: a variant of naevoid melanoma. Clinicopathological features and histological differential diagnosis.
    Blessing K; Grant JJ; Sanders DS; Kennedy MM; Husain A; Coburn P
    J Clin Pathol; 2000 Aug; 53(8):591-5. PubMed ID: 11002761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidermotropic xanthoma mimicking balloon cell melanoma.
    Northcutt AD
    Am J Dermatopathol; 2000 Apr; 22(2):176-8. PubMed ID: 10770441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response to 'Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation'.
    Markowitch W
    J Cutan Pathol; 2003 Apr; 30(4):284. PubMed ID: 12680963
    [No Abstract]   [Full Text] [Related]  

  • 46. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
    Fullen DR; Garrisi AJ; Sanders D; Thomas D
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
    Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
    J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of S100 antigenicity in metastatic melanoma.
    Aisner DL; Maker A; Rosenberg SA; Berman DM
    Hum Pathol; 2005 Sep; 36(9):1016-9. PubMed ID: 16153466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall.
    Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM
    Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of eleven cutaneous malignant melanomas in adults with small-cell morphology: emphasis on diagnostic difficulties and unusual features.
    Hanson IM; Banerjee SS; Menasce LP; Prescott RJ
    Histopathology; 2002 Feb; 40(2):187-95. PubMed ID: 11952865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
    Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
    Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of immunohistochemical studies using antibody to S100 protein in dermatopathology.
    Kahn HJ; Baumal R; Marks A
    Int J Dermatol; 1984; 23(1):38-44. PubMed ID: 6373634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regressed cutaneous malignant melanoma mimicking lymphoma: a potential diagnostic pitfall.
    Menasce LP; Shanks JH; Howarth VS; Banerjee SS
    Int J Surg Pathol; 2005 Jul; 13(3):281-4. PubMed ID: 16086086
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Desmoplastic malignant melanoma of the oral mucosa. An underrecognized diagnostic pitfall.
    Kilpatrick SE; White WL; Browne JD
    Cancer; 1996 Aug; 78(3):383-9. PubMed ID: 8697380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
    Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
    Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.
    Longacre TA; Egbert BM; Rouse RV
    Am J Surg Pathol; 1996 Dec; 20(12):1489-500. PubMed ID: 8944042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Top 10 Differential Diagnoses for Desmoplastic Melanoma.
    Fernandez-Flores A; Singh R; Cassarino DS
    Head Neck Pathol; 2023 Mar; 17(1):143-153. PubMed ID: 36928737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.